Congratulations to Noah
Congratulations to cc-TDI lab member, Noah Berlow PhD, whose cc-TDI spinout company, First Ascent, recently won a Portland-area startup challenge award!
Congratulations to cc-TDI lab member, Noah Berlow PhD, whose cc-TDI spinout company, First Ascent, recently won a Portland-area startup challenge award!
Some big news about tiny molecules: cc-TDI has recently been awarded an AIMS Award from Atomwise to create a molecularly-designed new drug for EWSR1 fusion
We are thrilled to announce the latest addition to our board of directors: Sharleigh Stevenson is President of the Australian non-profit Braver Stronger Smarter Incorporated and has been
Our research on Clear Cell Sarcoma (CCS) now includes an international collaboration. We have received samples from nearly every continent to study, but we have
We have some bright news for your Wednesday: The Gabriella Miller Kids First Research Act 2.0 is a bipartisan bill, which proposes that penalties from
We are thinking back to the recent past when we could have visitors in the lab and hopeful we can return to that mode someday
Even in this time of extreme uncertainty, particularly in healthcare, parents are still hearing the words: “your child has cancer” every single day. Cancer doesn’t
While much of the workforce is now working from home, we are excited to partner with IBM research. Folks who want to directly help cc-TDI
While much of the workforce is now working from home, you can join cc-TDI and IBM research! Do you want to directly help cc-TDI develop
We are excited to welcome Dr. Andrew Watson, Ph.D., C.L.P. to the cc-TDI Scientific Advisory Board. Dr. Watson is the Senior Director of the Oregon
Following is an excerpt from Dr. Charles Keller: “For childhood cancer, the potential for giving back childhood in the form of durable cures with minimal
Sometimes our team members are toiling away on behalf of perfect strangers. And sometimes they have a close, personal connection to the work they’re doing.
Hero Up for Children’s Cancer Foundation has funded a pilot research project at cc-TDI to better treat brain tumors that spread in the brain and
We attended and presented at the Third International Pediatric Liver Tumor Conference: Focus on High Risk Liver Cancers hosted by Cincinnati Children’s Hospital. The first
Two board members for the price of one! We were thrilled to recently welcome Tim and Heidi Frank to our Board of Directors. Their lives have been
We are grateful for the community that supports the family of Philomena and the Storm the Heavens Fund. For two years, the Storm the Heavens
Team members Charles, Andy, Greta and Stella were honored to attend the recent Sam Day Foundation “OneDaySamDay” soiree. The event featured a video from our Nanocourse which
We are thrilled to welcome John Grant to our Board of Directors. John’s list of credentials is much too lengthy to cover here, so please
We are excited to have a recent study published that benchmarks discovery compounds that turn off the NF-kB pathway in cancer. This was innovative study because
Congratulations to our team members Cora and Noah whose article on CIC-rearranged sarcomas was published recently in Cold Spring Harbor Laboratory Press Molecular Case Studies
Congratulations to cc-TDI lab member, Noah Berlow PhD, whose cc-TDI spinout company, First Ascent, recently won a Portland-area startup challenge award!
Some big news about tiny molecules: cc-TDI has recently been awarded an AIMS Award from Atomwise to create a molecularly-designed new drug for EWSR1 fusion
We are thrilled to announce the latest addition to our board of directors: Sharleigh Stevenson is President of the Australian non-profit Braver Stronger Smarter Incorporated and has been
Our research on Clear Cell Sarcoma (CCS) now includes an international collaboration. We have received samples from nearly every continent to study, but we have
We have some bright news for your Wednesday: The Gabriella Miller Kids First Research Act 2.0 is a bipartisan bill, which proposes that penalties from
We are thinking back to the recent past when we could have visitors in the lab and hopeful we can return to that mode someday
Even in this time of extreme uncertainty, particularly in healthcare, parents are still hearing the words: “your child has cancer” every single day. Cancer doesn’t
While much of the workforce is now working from home, we are excited to partner with IBM research. Folks who want to directly help cc-TDI
While much of the workforce is now working from home, you can join cc-TDI and IBM research! Do you want to directly help cc-TDI develop
We are excited to welcome Dr. Andrew Watson, Ph.D., C.L.P. to the cc-TDI Scientific Advisory Board. Dr. Watson is the Senior Director of the Oregon
Following is an excerpt from Dr. Charles Keller: “For childhood cancer, the potential for giving back childhood in the form of durable cures with minimal
Sometimes our team members are toiling away on behalf of perfect strangers. And sometimes they have a close, personal connection to the work they’re doing.
Hero Up for Children’s Cancer Foundation has funded a pilot research project at cc-TDI to better treat brain tumors that spread in the brain and
We attended and presented at the Third International Pediatric Liver Tumor Conference: Focus on High Risk Liver Cancers hosted by Cincinnati Children’s Hospital. The first
Two board members for the price of one! We were thrilled to recently welcome Tim and Heidi Frank to our Board of Directors. Their lives have been
We are grateful for the community that supports the family of Philomena and the Storm the Heavens Fund. For two years, the Storm the Heavens
Team members Charles, Andy, Greta and Stella were honored to attend the recent Sam Day Foundation “OneDaySamDay” soiree. The event featured a video from our Nanocourse which
We are thrilled to welcome John Grant to our Board of Directors. John’s list of credentials is much too lengthy to cover here, so please
We are excited to have a recent study published that benchmarks discovery compounds that turn off the NF-kB pathway in cancer. This was innovative study because
Congratulations to our team members Cora and Noah whose article on CIC-rearranged sarcomas was published recently in Cold Spring Harbor Laboratory Press Molecular Case Studies
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute